Keywords: Anemia, White cells, Rred cells, T- cells, Lymphadenitis, Hodgekin's disease, Emaciation, Leucopenia, Adenocarcinoma of sigmoid colon. Left semicolectomy, Metastatic lesion in the liver, Kaposi's sarcoma, Oral thrush, Oral herpes simplex infection, Hairy leukoplakia, Anti-HCV (+), Zidovudine (ZDV), CD4, Interferon-A-2b, Lesions, Antiretroviral treatment, Interferon administration, Aerosolized pentamidine, Pulmonary tuberculosis, Brain infarcts, HIV seropositive, Left semicolectomy, Ashler-Coller, Chemotherapy 5-FU, Lleucovorin, Analgesic effect, Fever, Pain, Interstitial pneumonia, Cotrimoxazole, Intestinal cryptosporidiasis,ZDV, DDI, DDC.

Case histories of AIDS patients who received treatment with the PAP IMI 300 device.

Patient No. 1
Male, 32 years old
Name initials : AG/KY
Code number : 199, homosexual, HIV seropositive since 4-93.

Kaposi's sarcoma lesions in his arms and left leg since 6-94. Started zidovudine (ZDV) and interferon-A-2b in 8-94. Lesions worsened and PAP IMI 300 treatments were applied in 2-95. Interferon administration was then stopped but antiretroviral treatment was continued. Following the PAP IMI 300 application, the patient's skin lesions remained stable and have continued to remain stable up to now (12-95). The patient feels better and stronger and he has gained weight. Consecutive CD4 counts (per mm3 ) were : 360 (8-94), 266 (1-95), 455 (4-5), 576 (6 -95), 558 (10-95). Blood count and biochemical values remained stable.

Patient No. 2
Female, 32 years old
Name initials : IO/GE
Code number : 99, heterosexual, HIV seropositive since 9-89.

Herpes Zoster of right leg (12-89), hairy leucoplakia (3-90), oral thrush (2-94), Kaposi's sarcoma lesions in her gums and palate (6-94). Interferon - A - 2b was administered concomitantly with antiretroviral therapy, which was begun in 3-90 (ZDV, DDI , DDC ).

She was also receiving aerosolized pentamidine ( allergic to cotrimoxazole ). On February 1995 she refused to take interferon any longer.

PAP IMI 300 treatments were begun in February and applied for three months.

During interferon treatment and PAP IMI 300 application, the oral lesions remained stable. Her CD4 counts (cells/mm3 ) were 187 (6-94), 60 (12-94) 235 (end of March 1995). But her compliance to the treatment regimen was rather poor. After three months we lost touch with her as she failed to continue her treatments. After a few months we learned that she was being followed up in another AIDS unit, where she had presented pulmonary tuberculosis and brain infarcts. Her CD4 count had dropped below 50 cells/mm3. In the absence of PAP IMI treatments CD 4 count is observed always to fall and never to spontaneously rise. So, although a CD4 count was not taken immediately prior to the commencement of PAP IMI treatments in 2-95, it can be assumed that the CD4 count at that time was below 60, and not above.

Patient No. 3
Male, 59 years old
Name initials : MI/GE
Code number : 261, homosexual, HIV seropositive since 2-94.

Adenocarcinoma of sigmoid colon (6-93). Left semicolectomy ( stage C2, Ashler-Coller ). Metastatic lesion in the liver (1-94). After the documentation of HIV-1 seropositivity, he is followed up in our department. He then received chemotherapy (5-FU plus leucovorin), antiretroviral therapy and interferon -A-2b. On May 1995 PAP IMI 300 treatments were applied due to constant pain in the right upper quadrant of his abdomen. Pain was significantly relieved and his general condition was improved. This analgesic effect lasted for several weeks. Subsequently, his compliance to treatment was not very good. Up to now he has shown no AIDS defining illness but other metastatic lesions appeared in the liver and lumbar spine. CD4 counts (cells /mm3 ): 212 (2-94), 40 (10-94 ), 284 (6-95). Although a CD4 count was not taken immediately prior to the commencement of PAP IMI treatments in 5-95, it can be assumed that the CD4 count at that time was below 40, and not above (see Case 3).

Patients No. 4
Male, 31 years old
Name initials : PA/ NI
Code number : 281, bisexual, HIV seropositive since 1989.

Kaposi's sarcoma lesions in skin and lung. PAP IMI 300 treatments were applied only 5 times (7-95). His clinical situation worsened rapidly and the patient died one month later. No comparable CD4 counts are available.

Patient No. 5
Male, 35 years old,
Name initials : KA/EV
Code number: 151, homosexual, HIV seropositive since 1-90.

He has shown no AIDS defining illness. Antiretroviral treatment since 11-93 ( ZDV, DDI, DDC). PAP IMI 300 treatments were applied in 7-95. 3TC plus ZDV were begun in 9-95. CD4 counts (cells/mm3): 215 (5-94), 156 (7-94), 154 (11-94), 138 (2-95), 128 (5-95), 119 (8-95), 378 (11-95). He is still being treated with the PAP IMI 300 and in excellent condition.

Patient No. 6
Male, 32 years old
Name initials : SE/MA
Code number : 131, homosexual, HIV seropositive since 1988. PCP (10-90).

Oral thrush (1-93). Oral herpes simplex infection (10-93). Hairy leukoplakia (2-95). Antiretroviral treatment and PCP prophylaxis since 10-90. From April 1995 he reported intermittent fever. PAP IMI 300 treatments were applied on 7-95. His general condition improved. Fever kept recurring to a lesser degree. 3TC plus ZDV begun on 9-95. Now he is in almost excellent condition and is still on the PAP IMI 300. CD4 counts (cells/mm3): 11 (1-95), 6 ( 4-95 ), 12 (7-95), 5 (9-95), 4 (10-95).

Patient No. 7
Male, 34 years old
Name initials : VA/ IO
Code number : 260, bisexual, HIV seropositive since 1988. PCP (9-94).

CMV retinitis (10-95). Antiretroviral therapy since 2-94 (AZT, DDI, 3TC plus ZDV). PAP IMI 300 treatments were applied on 7-95 (only a few applications). No comparable results have been forthcoming.

Patient No. 8
Male, 29 years old
Name initials : PS/PO
Code number : 259, homosexual, HIV seropositive since 1988.

Oral thrush (4-95). No AIDS defining illness. Antiretroviral therapy since 2-94 (ZDV, DDI, DDC ). PAP IMI 300 treatments were applied on 7-95. He remains in good condition. He began 3TC+ZDV on 9-95. CD4 counts (cells/mm3 ) : 63 (3-95 ), 55 ( 9-95 ), 56 (10-95).

Patient No. 9
Male, 49 years old
Name initials : PA/KO
Code number : 28, bisexual, HIV seropositive since 5-85.

Oral herpes simplex infection (7-94). Oral thrush (2-95). Anti-HCV (+) since 2-95. Antiretroviral treatment since 2-89 ( ZDV, DDI, DDC). PAP IMI 300 treatments were applied on 7-95. He remains in a rather good and stable condition. CD4 counts (cells/mm3): 7(11-94), 2 (6-95), 3 (10-95).

Patient No. 10
Male, 50 years old
Name initials : CH/KO
Code number : 305, homosexual, HIV seropositive since 5-95.

Interstitial pneumonia resolved with cotrimoxazole (6-95). Oral thrush (6-95). Intestinal cryptosporidiasis (6-95). Kaposi's sarcoma in nose and left malar area (7-95). Treatments with the PAP IMI 300 were applied (7-95) and interferon-A -2b was administered (7-95). Lesions remained stable. Antiretroviral treatment since 6-95 (ZDV). CD4 counts (cells/mm3): 190 (6-95), 60 (9-95).

Patient No. 11
Male, 29 years old
Name initials : KA/IO
Code number: 212, bisexual, HIV seropositive since 3-92.

Antiretroviral treatment since 2-95 (ZDV). Varicella (6-95).
Treatments with the PAP IMI 300 were applied on 10-95. He remains in very good condition. CD4 counts (cells/mm3 ): 296 (2-95), 342 (5-95 ), 356 (9-95), 303 (12-95).
Viral load measurements are pending.

Patient No. 12
Female, 26 years old
Name initials : KA/MA
Code number : 255, heterosexual, HIV seropositive since 2-92.

Wife of patient No 11. Antiretroviral treatment since 3-94. Varicella (6-95).
Treatment with the PAP IMI 300 was applied on 10-95.
She is in excellent condition. CD4 counts (cells/mm3 ): 440 (3-94), 578 (9-94), 488 (5-95), 463 (9-95), 415 (12-95). Viral load measurements are pending.

Conclusion

In conclusion, in four of our patients we noticed an improvement of their clinical condition, in 6 their condition remained stable, while one patient showed a worsening. The Kaposi's sarcoma lesions remained at least stable during the application period. An increase of CD4 count was demonstrated in four of our patients. The increase was quite remarkable in some of them. In three, the CD4 count remained rather stable while there was a worsening in four of them. The study was approved by the Greek National Drug Organization. It is also noteworthy that all patients have experienced no side effects or adverse reactions during or after the PAP IMI 300 application. We must also note that all patients were receiving antiretroviral treatment as well all the appropriate prophylactic regimens.

Dr. Anthony Papadopoulos, Dr. John Arkadianos and Dr. Anthony Scoullos are actively working on this study.
Dr. George D. Stergiou, MD Director 2nd Department of Internal Medicine and AIDS Unit 1st IKA HOSPITAL Athens, GREECE

Keywords: Adeno-carcinoma, Anemia, ancer of the left breast, Cancer of multiple locations, Cancerous tumor of the large intestine, Cancerous tumor of the left breast, Ovarian cyst, Rheumatic diseases,Asthma, Intestinal ulcers, Stomach ulcers, Burning, Fractures, Eye problems, Brain damage, Dermatopathy, Inflammatory diseases, Cosmetology, Fatigue, Lymphadenitis, Hodgkin's disease, Fever, antibiotic intake, pneumonia carinii, diarrheal syndrome, AIDS virus, CD4, Iron capsules (Microferrer), diarrhea, AZT, Kathidermo H. F, DDI, and 3TC, Lmphadenitis of cervical lymph nodes, Non-Hodgkin's, X ray.

Treated by Nick Tsilimigakis, MD
at the Scientific Institute for Bioenergy
Glyfada, Athens, Greece
Dr. Nick Tsilimigakis Protocol
THE TSILIMINGAKIS METHOD

Dr Nick Tsilimingakis developed a brand new method, were three devices are employed

In addition he uses a unique formula of vitamin and mineral supplements.specially designed to work synergistically with PAP IMI electrotherapeutic ma…………..

The devices are

• a) an electronic acupuncture device this device administers to the patient DC square wave pulses (30 - 60 volts) the frequency is subject to slight variations, according to the specific patient, and is approximately 10 Hertz
• b) an ammeter diagnostic device for assessing the patient's body electro-balance condition by measuring body conductivity, and
• c) the PAP IMI device that administers high power, short duration magnetic pulses.

Microcurrent treatment:

Gold plated acupuncture needle electrodes are inserted vertically to a depth of about half a centimeter (3 to 5 millimeters) into the web between the thumb and forefinger of each hand. About 30 to 60 volts in the form of 10 Hertz DC square wave pulses, generated by a WO-10B Multiple Electronic Acupunctoscope, is administered to the patient for about half an hour via the implanted electrodes. The voltage is gradually increased until the patient's tolerance level is reached. The polarity is chosen so that the right hand needle is made positive. The treatment is done twice a week until the patient's tissue conductivity is raised to a level typical of a healthy individual, as measured by the body electrobalance diagnosis technique described below.

Body electro-balance diagnosis technique:

The body electro-balance diagnosis technique is carried out by using a Kathidermo H. F. device which measures the body's tissue conductivity (milliamp current conduction) while applying 45 volts DC to a pair of 1.5 cm diameter tubular hand grips held tightly in each palm. The Kathidermo is a constant current 45 volt power supply. So regardless of the value of the patient's body conductivity, the power supply delivers a constant flow of current which may be increased by turning a knob on the control panel. The current flow is progressively increased until the patient's tolerance level is reached, at which point the amount of current (i) being delivered is read from a meter. The patient's body conductivity is then calculated accordingly (i.e., conductivity = i/45 volts). Ill patients are found to have low tissue conductivities, drawing less than 4 milliamps at 45 volts, often as low drawing as little as 2 to 3 milliamps (45 to 65 micro mhos). Healthy patients generally yield currents of 4 to 5 milliamps (90 to 110 micro mhos).

The measurements are fairly consistent.

Most of the conductivity includes passage along the left and right hand and the upper body. The skin resistance contributes a smaller part. Most of the conductivity may be due to the electrolytic conductivity of the blood.

With progressive microcurrent treatments, the measured body conductivity is found to increase fairly consistently over a period of one to several months, rising from initially low unhealthy values to more normal values of around 4 milliamps per 45 volts. During the same time, the physical condition of the patient improves accordingly.

PAPIMI treatment:

The patient is usually treated with PAP IMI device for about 20 minutes twice each week. He receives these treatments with the same frequency as with the microcurrent device. He treats for about 6 to 18 minutes locally on the infected region or area that is giving problems and for about 6 minutes on the thymus for general immune system stimulation. In case pain develops in the treated location, the doses are reduced locally or discontinued for a period of time and then repeated according to the normal protocol. Otherwise significant irritation and pain may develop. The microcurrent treatments are done in conjunction with the PAP IMI treatments until the patient's body electrobalance has achieved the proper level.

Thereafter, the patient receives just PAP IMI treatments. More about the combination therapy: The microcurrent and PAP IMI treatment techniques were found to mutually benefit one another. Roughly speaking, the effectiveness of either technique used in isolation was found to be improved by 10 fold when both were used together. Improved tissue conductivity, body electro balance, not only improves the general condition of the patient, but also prepares the patient's body to better receive the PAP IMI treatments, thereby enhancing their effectiveness.

In general Dr. Tsilimigakis prescribes vitamins and trace metal minerals to his patients. For AIDS he prescribes large doses of vitamin C (beginning with 6 grams per day for the first week) and minerals (about one tablet per day), the particular dosage being dependent on their condition. For example, if the patient has diarrhea, the dose is reduced to a point which may be tolerated. Subsequently, Dr. Tsilimigakis adjusts the dose according to the condition, using his own experience and intuition.

Usage of PAP IMI: In all cases, except AIDS Case 1, the PAP IMI was used from the beginning of the patient's therapy in conjunction with the microcurrent therapy. In AIDS Case 1, the patient began with microcurrent therapy and after 21 months her treatments began to be supplemented with PAP IMI treatments, whereupon her recovery accelerated significantly.

Case 1.
Patient: S.T.
Female, 30 years old

Therapy period: November, 1992 - present

A. Method of therapy:

1. Use of diagnostic device for assessing the patient's body electro-balance condition,
2. Use of the micro-current device,
3. Use of the PAP IMI device beginning in August 1994. At the beginning of the therapy, the patient was also receiving AZT, but stopped some months after beginning the PAP IMI treatments.

B.Clinical condition before beginning therapy:

Significant fatigue, lymphadenitis, Hodgkin's disease, emaciation, weight down to 46 kg (101 lb).

C. Laboratory findings before beginning therapy:

Anemia, leukopenia, CD4 count = 29.

Patient development during therapy:

1. Patient began microcurrents therapy in November 1992. During the first month of therapy: A significant improvement of the physical condition, recession of the anemia, restitution of the white cell count to normal levels, a weight increase of 3 kg (6.6 lb), and an improvement of body electro-balance indices.
2. By the end of the second month of therapy: Excellent physical condition, normal counts for red and white blood cells, a weight increase of 4 kg (9 lb), body electro-balance field indices return to normal.
3. By the end of the six month of therapy: Excellent physical condition, full vocational activities, a complete reduction in lymph node swelling, weight recovery to pre-illness level: 56 kg (123 lb), CD4 count = 90
4. By the end of the first year of therapy: Clinical condition is excellent, CD4 count = 120.
5. By end of the second year of therapy: Clinical condition is excellent. Note that the treatment is supplemented with PAP IMI treatments in the ninth month of this second year of therapy (August 1, 1994). Treatments are given to the thymus region. The patient's recovery accelerates.
6. On June 25, 1994: CD4 count = 168. On December 9, 1994: CD4 count = 312, almost doubling in 5- months. Excited and encouraged with the unexpected increase, the patient travels to France and discontinues therapy for 4 months, whereupon CD 4 count drops by two-thirds - On April 24, 1995 CD4 =201. Thereafter, the patient recontinues therapy.
7. By the end of the third year of treatment in December 1995: CD4 count has climbed to 350. During this year, no other medication for HIV is being taken. Physical condition is excellent.
8. Again encouraged by the increase in T cell count, the patient leaves treatment. A blood test made in June indicates a CD4 = 230, indicating that her CD4 count again had dropped by two-thirds in the intervening 6 months.

However, more recently in October 1996 she and her doctors reported that test results showed that the AIDS virus had dropped below detectable levels in her blood! In the intervening 10 months since she discontinued PAP IMI treatments she had taken no other AIDS therapy.

Case 2.
Patient: K.H.
Male, 60 years old

A. Method of treatment:

1. Use of diagnostic device for assessing the patient's body electro-balance condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of large doses of vitamin C,
5. Intake of trace minerals.

B. Clinical condition before treatment:

Significant fatigue, emaciation, continuous fever 40-42x C (104-107.6x F) for two months with no response to continuous antibiotic intake, pneumonia carinii, diarrheal syndrome.

C. Laboratory findings before treatment:

Anemia, leukopenia, CD4 count = 10.

D. Patient development during treatment application:

1. With the application of the Tsilimigakis therapy and with all the antibiotics being discontinued, during the first 10 days the patient's temperature dropped to 37-37.5x C (98.6-99.5x F).
2. By the end of the second month of treatment the patient shows complete restitution of his body electro-balance condition. Patient's physical condition has become excellent, significant improvement to the laboratory indices. Patient returns to work. CD4 count = 24. Complete cure from pneumonia. Weight increases by 4 kg (9 lb).
3. By the end of the first semester: Excellent physical condition. Lung X ray examination - normal, weight recovery to normal from 60 kg (before) (132 lb), to 76 kg (after) (168 lb). To our knowledge no medication against HIV was taken by the patient during the entire period of the therapy.

Case 3.
Patient: B. D.
Male, 47 years old

A. Method of treatment:

1. Use of diagnostic devices for assessing the patient's body electro-balance condition.
2. Use of the microcurrent device,
3. Use of the PAP IMI
4. Intake of soluble Vitamin C (6 grams/day for first week and 1 gram/day thereafter), trace minerals, multivitamins, iron. Iron capsules (Microferrer) were given for treatment of anemia.

B. Clinical condition before treatment:

Significant fatigue, significant emaciation, continuous diarrheal syndrome, excessive anemia.

C. Laboratory findings before treatment:

Anemia, HT = 22, leukopenia, CD4 count = 30.

D. Patient development during treatment application:

The application of Dr. Tsilimigakis' treatment resulted in a significant improvement of the patient's physical condition during the first month. Weight increased by 4 kg (9 lb). There was significant improvement in the laboratory findings. The body electro-balance condition got to the normal level for healthy persons. Diarrhea became intermittent. Patient returned to his work. By the end of the first semester, patient had an excellent physical condition, regained normal body weight. On September 11, 1995: CD4 count = 113. Patient was not taking any medication against HIV.

Case 4.
Patient: B. A.
Male, 30 years old

A. Method of treatment:

1. Use of diagnostic devices for assessing the patient's body electro-balance condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of large doses of vitamin C,
5. Intake of vitamins and trace minerals.

B. Clinical condition before treatment:

Significant fatigue, emaciation, continuous fever 38-39x C (100-102x F), diarrheal syndrome, weight 56 kg (123 lb).

C. Laboratory findings before treatment:

Anemia, significant reduction of blood platelet count (28,000), CD4 count = 70, significant reduction of white cell count.

D. Patient's development during treatment application:

a. During the first two weeks, the patient showed improvement in his physical condition, weight increased by 2 kg (4-1/2 lb), reduction in the frequency of diarrhea.
b. By the end of the first month of therapy the patient exhibited a sufficiently good physical condition, weight increased by 3 kg (6-1/2 lb) [total increase in the first month 5 kg (11 lb)]. Diarrhea stopped completely. Laboratory verified improvement of anemia, HT = 31, restitution of white cells to a normal healthy level. Platelet count increased to 48,000. Patient was able to leave the hospital to receive the Tsilimigakis treatment and was receiving combinations of AZT, DDI, and 3TC.

Case 5.
Patient: M. K.
Male, 30 years old

A. Method of treatment:

1. Use of diagnostic devices for assessing the patient's body electro-balance condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of large doses of vitamin C,
5. Intake of trace minerals.

B. Clinical condition before treatment:

Significant fatigue, excessive lymphadenitis of cervical lymph nodes due to non-Hodgkin's disease lymphoma

C. Laboratory findings before treatment:

Anemia, reduction of white cell count, CD4 count = 300.

D. Patient's development during treatment application:

a. By the end of two weeks, the patient shows improvement of his physical condition, reduction in the swelling of cervical lymph nodes.
b. By the end of the first month: Excellent physical condition, further reduction of swollen cervical lymph nodes. Laboratory tests for red and white cells are normal.
c. By the end of the second month, the lymphoma swelling had entirely disappeared. The patient was taking AZT, DDI and had been through chemotherapy without any positive effect.

Case 6.

A. Method of treatment:

1. Use of a diagnostic device for assessing the patient's body electro-balance condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of vitamins and minerals.

B. Patient development during treatment application:

The patient was HIV positive but had no symptoms of AIDS. The method was applied provisionally three times per week over a one month period. There was a significant increase of CD4 cells: initial CD4 count = 320, rises to CD4 = 450 after one month, without any drug intake.

Case 7.

A. Method of treatment:

1. Use of a diagnostic device for assessing the patient's body electro-balance condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of vitamins and minerals.

B. Patient development during treatment application:

The patient was HIV positive but had no symptoms of AIDS. The method was applied provisionally three times per week over a one month period. There was a significant increase of CD4 cells: initial CD4 count = 410, rises to CD4 = 650 after one month, without any drug intake.

Suggestions for Optimizing the Treatment Method:

A. Patients usually leave treatment after two months because:

1. they are encouraged by the significant improvement of their physical condition and
2. because of financial difficulty to self cover the treatments (not yet covered by health insurance). As a result, they do not follow our recommendations and instead decrease the number of treatments they receive.

B. Similarly, there is a problem of follow up and of retrieving laboratory examinations taken in major hospitals where the AIDS patients initially report and receive treatments. Major hospitals are unwilling to cooperate in carrying out examinations we recommend, as well as in providing existing results.

C. I suggest two solutions to this problem. The first is a short term solution, namely to provide financial support to supplement the expenses for the patient's therapy and required examinations. The second solution is to set up a specialized center in the form of a clinic or hospital for the proper self application of the therapy method. Presently, the application of the method involves many problems and difficulties, and as a result does not attain the efficacy which ideally could have been achieved.

D. Follow up for patients treated for AIDS and other major diseases, the patient's body electro-balance condition is very important. Many years of experience and many stages of research have taught us what is seen daily in curative medicine, i.e., that patients with more serious adverse prognoses often complete more successful follow ups as compared with others that have less serious adverse prognoses. A decisive factor is the general condition of the patient's body electro-balance, which does not show up in partial laboratory findings and prognosis.

If the patient's state defined by all his laboratory and clinical findings is represented as A, and if the state of his body electro-balance condition -not included in his laboratory and clinical description - is represented as B, then his true condition is the resultant of both states A and B, given by their product AxB. This is confirmed in the above cases which show that the patient's overall condition immediately following body electro-balance treatments is much better and optimistic than the condition expected by the laboratory findings alone.

In the present situation, the diagnosis of a patient's body electro-balance condition is considered very important for setting the plan for his therapy.

E. The present therapeutic method, besides having application to AIDS, has also been used to successfully treat various types of cancer. As indicated by the impressive and increasing number of successes, the technique has also yielded positive results with the following:

Rheumatic diseases,
Asthma,
Intestinal and stomach ulcers,
Burning and various edemas,
Fractures with an impressive speed of healing,
Eye problems and conditions,
Brain damage,
Dermatopathy and skin diseases,
Various inflammatory diseases,
Cosmetology.

This method may also provide significant results in the prognosis and prevention of diseases as well as in retarding the cellular aging process.

Nick Tsilimigakis, MD
December 14, 1995
Updated: 9/20/96 & 10/15/96

The cancer cases treated with this treatment protocol include the following

Case 1 (male): Adeno-carcinoma in the abdomen and anemia.
Case 2 (female): Adeno-carcinoma of the lungs and epidermal cancer of the left breast.
Case 3 (female): Cancer of multiple locations with major lung location.
Case 4 (male): Cancerous tumor of the large intestine following surgery.
Case 5 (female): Cancerous tumor of the left breast - tumor was size of small orange.
Case 6 (female): Ovarian cyst, comparable in size to a small orange.

Case 1.
Patient: D. I.
Male, 60 years old

• A. Clinical condition before treatment: Severe loss of energy, patient not subject to any further known medical treatment for his condition after three surgeries and several chemotherapies, according to diagnosis of Professor G. Philippakis of the University of Athens, Medical School.  
• B. Laboratory findings before treatment: Extended adeno-carcinoma in the abdomen, anemia.
• C. Method of treatment:

1. Use of a diagnostic device for assessing the patient's bioenergy condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of vitamins and minerals.

Case 2.
Patient: Mrs A. D.
Female, 70 years old

Suffers from adeno-carcinoma of the lungs and epidermal cancer of the left breast. She takes the therapeutic method of Dr Tsilimigakis for one month:

• B. Method of treatment:

1. Use of a diagnostic device for assessing the patient's bioenergy condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of vitamins and minerals.

Her physical condition has significantly improved, as well as the measurements of her bioenergy condition. For the epidermal cancer a special localized corona exposure (high frequency arc) is given. The tumor has already significantly diminished. The patient continues therapy.

Case 3.
Patient: M. M.
Female, 54 years old

Cancer of multiple locations with major lung location.

• B. Method of treatment:

1. Use of a diagnostic device for assessing the patient's bioenergy condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of vitamins and minerals.

X ray inspection after one month from the beginning of our therapy showed a significant reduction of the lung carcinoma. Therapy is still underway.

Case 4.
Patient: Mr. K. A.
Male

The patient underwent surgery to remove a cancerous tumor of the large intestine. Following surgery, he began taking our therapy.

• B. Method of treatment:

1. Use of a diagnostic device for assessing the patient's bioenergy condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of vitamins and minerals.

Results during the past 8 months: Patient's physical condition, laboratory tests, and bioenergy condition have improved to excellent. Biopsy of a small tumor left over from his last surgery shows the remnant tumor is no longer malignant, but benign! Also normal cell growth has taken the place of the cancerous tumor. The therapy continues.

Case 5.
Patient: C. P.
Female, 46 years old

Tumor of the left breast, cancerous in nature. Tumor is comparable in size to a small orange.

• B. Method of treatment:

1. Use of a diagnostic device for assessing the patient's bioenergy condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of vitamins and minerals.

The tumor disappeared after two months of therapy.

Case 6.
Patient: Maria T.
Female, 26 years old

• A. Clinical condition before treatment:

Ovarian cyst, comparable in size to a small orange.

• B. Method of treatment:

1. Use of a diagnostic device for assessing the patient's bioenergy condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of vitamins and minerals.

Ovarian cyst completely disappeared in 15 days. Confirmed by before-and-after ultrasound examinations.

Case 7.
Patient: K. S.
Male, 60 years old

(A case of lung adeno-carcinoma and cancers of the lung and cervical lymph nodes.)

• A. Clinical condition before treatment:

The patient had lung adeno-carcinoma as well as cancers of the lung and cervical lymph nodes. On November 10th, 1995 he was given short notice that he was expected to live another 10 days. The hospital doctors attending him sent him home to die without knowing of anything else they could do for him. After visiting me for the first time on November 13th, 1995. the patient began applying my method,

• B. Method of treatment:

1. Use of a diagnostic device for assessing the patient's bioenergy condition,
2. Use of the microcurrent device,
3. Use of the PAP IMI device,
4. Intake of vitamins and minerals.

Within one month without undergoing any other medical treatment, the excessive size of the patient's cervical lymph nodes had completely disappeared and he had regained excellent physical condition. Upon reexamining him, his previous hospital doctors were astonished and amazed. Therapy continues today.

Nick Tsilimigakis, MD
December 14, 1995